- Conducted diligence for clinical-stage life sciences and medtech investments, focused on immuno-oncology, cardiology, neurology, and rare diseases for a $125M venture fund.- Notable investments: Acesion Pharma, Odyssey Therapeutics, Nuvig Therapeutics, and ShiraTronics.

- Training in internal medicine with core rotations in oncology, hematology, cardiovascular, pulmonary, and general internal medicine at #2 ranked hospital in the nation.

- Edit articles to distill complex medical conditions and cutting-edge research into clear, accessible information for the general public.

- Advising for drug-delivery technologies to advance women's health- Assisted with capital fundraise, technology development, and corporate strategy for new women's health technology

Primary author on over a dozen peer-reviewed articles aimed to better inform patients on cardiovascular disease. Featured on website with over 800 million page views. https://www.verywellhealth.com/kevin-cyr-bio-5180013

Aggregated weekly health news content for startup and disseminated multimedia news to 100 million beneficiaries in the Anthem Blue Cross Network on a weekly basis

Led due diligence projects for Charles River Ventures evaluating seed-stage biotech, pharmaceutical, and diagnostics companiesParticipated in deal flow and ongoing investments discussions for two early-stage biotech investments

Project based experience developing methods, protocols, procedures, and quality control documentation for a novel drug delivery technology. Gained exposure to the medical, business, and research developments within a new and rapidly growing life-sciences company.

Developed personal research projects spanning multiple disciplines including: • A portable nanofiber delivery system for wound healing. Presented at the 2014 Biomedical Engineering Society Annual Conference in San Antonio, TX • A low cost paper-based diagnostic device to detect Sickle Cell Disease in sub-Saharan Africa. Presented at the 2015 Biomedical Engineering Society Annual Conference in Tampa Bay, FL • Swyft Health: A cloud based app for real time disease monitoring. The app employs disease modeling, machine learning algorithms, and real time data collection to accurately evaluate disease spread in a metropolitan area.

Studied CAR T cell immunotherapy and therapeutics to manage Graft-versus-host disease (GVHD) in the laboratory of Qing Ma. Earned a finalist spot in the MD Anderson Cancer Center Elevator Pitch contest for summer research participants.

Developed a tissue engineered model of a human lung using mesenchymal stem cells in the Nichols-Cortiella laboratory. Project earned a 2nd place award at the Intel International Science and Engineering Fair in 2013.